Sarcoidosis

Crofton and Douglas's Respiratory Diseases: Fifth Edition

Volumn 2, Issue , 2008, Pages 1035-1062

  Leitch, A Gordon ^a  

^a NONE

Author keywords

Granulomas; Hypercalciuria; Immunoglobulins; Lymphadenopathy; Sarcoidosis

Indexed keywords

EID: 0012502656     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470695999.ch39     Document Type: Chapter

References (303)

1. James DG, Turiaf J, Hosoda Y et al. Description of sarcoidosis: Report of the subcommittee on classification and definition. Ann N Y Acad Sci 1976; 278: 742.
2. Hunter FT. Hutchinson-Boeck's disease (generalised sarcoidosis). N Engl J Med 1936; 214: 346.
3. Hutchinson J. Illustrations of Clinical Surgery. London: J & AChurchill, 1877: 42.
4. Scadding JG, Mitchell DN. Sarcoidosis, 2nd edn. London: Chapman & Hall, 1985.
5. Besnier E. Lupus pernio de la face. Ann Derm Syph Paris 1889; 10: 333.
6. Tenneson H. Lupus pernio. Ann Derm Syph Paris 1892; 3: 1142.
7. Hutchinson J. Cases of Mortimer's malady. Arch Surg Lond 1898; 9: 307.
8. Boeck C. Multiple benign sarkoid of the skin. J Cutan Dis 1899; 17: 543.
9. Kreibich K. Uber lupus pernio. Arch Derm Syph Wien 1904; 71: 3.
10. Boeck C. Fortgesetze Untersuchungen uber das multiple benigne Sarkoid. Arch Derm Syph Wien 1905; 73: 301.
11. Darier J, Roussy G. Des sarcoides souscutanees. Arch Med Exp 1906; 18: 1.
12. Heerfordt CF. Uber eine 'Febris uveoparotidea subchronica'. von Graefes Arch Ophthal 1909; 70: 254.
13. Schaumann J. Sur le lupus pernio. Memoire presenté en Novembre 1914 a la Societé Francoise de Dermatologie et de Syphiligraphie pour le prix Zambo, Stockholm, 1934.
14. Schaumann J. Etudes sur le lupus pernio et ses rapports avec les sarcoides et la tuberculose. Ann Derm Syph Paris 1917; 5:357.
15. Jungling O. Ostitis tuberculosa multiplex cystica (eine eigenartige Form der Knockentuberculose) Fortschr Röentgenstr 1920; 27:375.
16. Lofgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946; Suppl 174.
17. Lofgren S. Primary pulmonary sarcoidosis. Acta Med Scand 1953; 145: 424, 465.
18. Morrison JGL. Sarcoidosis in the Bantu. Br J Dermatol 1974; 90: 649.
19. Proceedings of the Third International Conference on Sarcoidosis, 1963. Acta Med Scand 1964; Suppl 425.
20. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. Am Rev Respir Dis 1984; 130: 29.
21. Anon. Sarcoidosis in the long-term. Lancet 1984; ii: 674.
22. Poukkula A, Huhti E, Lilja M, Saloheimo M. Incidence and clinical picture of sarcoidosis in a circumscribed geographical area. Br J Dis Chest 1986; 80: 138.
23. Parkes SA, Baker SBdec, Bourdillon RE et al. Incidence of sarcoidosis in the Isle of Man Thorax 1985; 40: 284.
24. British Thoracic and Tuberculosis Association. Geographical variations in the incidence of sarcoidosis in Great Britain: a comparative study of four areas. Tubercle 1969; 50: 211.
25. Cooch JW. Sarcoidosis in the United States Army, 1952 through 1956. Am Rev Respir Dis 1961; 84 (Suppl): 103.
26. James DG, Neville E, Siltzbach LE et al. A worldwide review of sarcoidosis. Ann N Y Acad Sci 1976; 278: 321.
27. Douglas AC. Sarcoidosis in Scotland. Am Rev Respir Dis 1961; 84 (Suppl): 143.
28. Douglas AC. Sarcoidosis. Proc R Soc Med 1967; 60: 983.
29. Israel HL. Sarcoidosis. Basics RD 1978; 7: 1.
30. Lofgren S. Some aspects of the relationship between tuberculosis and sarcoidosis. Transactions of NAPT Fourth Commonwealth Health and Tuberculosis Conference. London: National Association for the Prevention of Tuberculosis, 1955.
31. Douglas AC. The prognosis of early sarcoidosis. Acta Med Scand 1964; Suppl 425:284.
32. Israel HL, Sones M. Sarcoidosis. Adv Tuberc Res 1961; 11: 214.
33. Hosoda Y, Hirga Y, Furuta M et al. Epidemiology of sarcoidosis in Japan. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Tokyo:University Press, 1974: 297.
34. Edmonstone WM, Wilson AG. Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest 1985; 79: 27.
35. Honeybourne D. Ethnic differences in the clinical features of sarcoidosis in south-east London. Br J Dis Chest 1980; 74: 63.
36. Teirstein AS, Siltzbach LE, Berger H. Patterns of sarcoidosis in three population groups in New York City. Ann N Y Acad Sci 1976; 278: 371.
37. British Thoracic and Tuberculosis Association Research Committee Investigation. Familial associations in sarcoidosis. BTTA review. Tubercle 1972; Suppl 3: 41.
38. Headings VE, Weston D, Young RC, Hackney RL. Familial sarcoidosis with multiple occurrences in eleven families: a possible mechanism of inheritance. Ann N Y Acad Sci 1976; 278: 377.
39. Sharma OP, Neville E, Walker AN, James DG. Familial sarcoidosis: a possible genetic influence. Ann N Y Acad Sci 1976; 278: 386.
40. Brennan NJ, Crean P, Long JP, Fitzgerald M. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984; 39: 14.
41. Parkes SA, Baker SBdec, Bourdillon RE et al. Epidemiology of sarcoidosis in the Isle of Man. 1. Acase controlled study. Thorax 1987; 42: 420.
42. Hills SE, Parkes SA, Baker SBdec. Epidemiology of sarcoidosis in the Isle of Man. 2. Evidence for space-time clustering. Thorax 1987; 42: 427.
43. Brewerton DA, Cockburn C, James DCO et al. HLAantigens in sarcoidosis. Clin Exp Immunol 1977; 27: 227.
44. Neville E. HLA antigens and disease. J Mt Sinai Hosp 1977; 44: 772.
45. Neville E, James DG, Brewerton DA et al. HLAantigens and clinical features of sarcoidosis. In: Jones Williams W, Davies BH, eds. Proceedings of the Eighth International Conference on Sarcoidosis and other Granulomatous Diseases. Cardiff: Alpha Omega, 1980: 201.
46. Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis. Tissue Antigens 1983; 22: 200.
47. Gardner J, Kennedy HG, Hamblin A, Jones E. HLA-associations in sarcoidosis: a study of two ethnic groups. Thorax 1984; 39: 19.
48. Abe S, Yamaguchi E, Makimura S et al. Association of HLA-DR with sarcoidosis. Chest 1987; 92: 488.
49. Kunikane H, Abe S, Tsuneta Y et al. Role of HLA-DR antigens in Japanese patients with sarcoidosis. Am Rev Respir Dis 1987; 135: 688.
50. Ina Y, Takada K, Yamamoto Met al. HLA and sarcoidosis in the Japanese. Chest 1989; 95: 1257.
51. Mitchell DN, Rees RJW. Atransmissible agent from sarcoid tissue. Lancet 1969; ii: 81.
52. Mitchell DN, Rees RJW. Agent transmissible from Crohn's disease tissue. Lancet 1970; ii:168.
53. Iwai K, Takahashi S. Transmissibility of sarcoid-specific granulomas in the footpads of mice. Ann N Y Acad Sci 1976; 278: 249.
54. Taub RN, Sachar DB, Janowitz H, Siltzbach LE. Induction of granulomas in mice by inoculation of tissue homogenates from patients with inflammatory bowel disease and sarcoidosis. Ann N Y Acad Sci 1976; 278:56.
55. Mitchell DN, Rees RJW. The nature and physical characteristics of a transmissible agent from human sarcoid tissue. Ann N Y Acad Sci 1976; 278: 233.
56. Mitchell DN, Rees RJW, Goswami KKA. Transmissible agent from human sarcoid and Crohn's disease tissues. Lancet 1976; ii:761.
57. Mitchell DN, Bradstreet CMP, Dighero MW et al. Irradiated Kveim suspensions. Lancet 1974; i: 734.
58. Mitchell DN, Rees RJW. The nature and physical characteristics of transmissible agents from human sarcoid and Crohn's disease tissues. In: Proceedings of the Ninth International Conference on Sarcoidosis. Oxford: Pergamon Press, 1983: 132.
59. Burnet FM. The Clonal Selection Theory of Acquired Immunity. Cambridge: Cambridge University Press, 1959: 160.
60. Mitchell IC, Turk JL, Mitchell DN. Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet 1992; 339:1015.
61. Saboor SA, Johnson NMcI McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339: 1012.
62. Bocart D, Lecossier D, DeLassence A et al. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992; 145: 1142.
63. Anon. 'Tastes great, less filling.' The debate about mycobacteria and sarcoidosis. Am Rev Respir Dis 1992; 145: 986.
64. Johnson BA, Duncan SR, Ohori NP et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis 1993; 148: 1373.
65. Martinez FJ, Orens JB, Deeb M. Recurrence of sarcoidosis following bilateral allogeneic lung transplantation. Chest 1994; 106: 1597.
66. Werb Z, Gordon S. Secretion of a specific collagenase by stimulated macrophages. J Exp Med 1975; 142: 346.
67. Werb Z, Gordon S. Elastase secretion by stimulated macrophages. J Exp Med 1975; 142: 361.
68. Gallily K, Ben-Ishay Z. Immune cytolysis of mono- macrophages in vitro. J Reticuloendothelial Soc 1975; 18: 44.
69. Mebom H, Sanner T, Seljelid R. Macrophage cytolytic factor: some observations on its physicochemical properties and mode of action. Exp Cell Res 1975; 94: 221.
70. McLelland DBL, Van Furth R. In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology 1975; 28:1099.
71. Hinman LM, Stevens CA, Matthay RA, Gee JBL. Angiotensin convertase activities in human alveolar macrophages: the effects of cigarette smoking and pulmonary sarcoidosis. Science 1979; 205: 202.
72. Spector WG. Epithelial cells, giant cells and sarcoidosis. Ann N Y Acad Sci 1976; 278: 3.
73. Soler P, Bassett F, Bernaudin JF, Chretien JF. Morphology and distribution of sarcoid granuloma: ultrastructural study of serial sections. Ann N Y Acad Sci 1976; 278: 147.
74. Semenzato G, Zezzutto A, Pizzola G et al. Immunohistological study in sarcoidosis:evaluation at different sites of disease activity. Clin Immunol Immunopathol 1984; 30: 29.
75. Fazel SB, Howie SEM, Krajewski AS, Lamb D. B lymphocyte accumulations in human pulmonary sarcoidosis. Thorax 1992; 47: 964.
76. Uehlinger EA. The morbid anatomy of sarcoidosis. Am Rev Respir Dis 1961; 84 (Suppl):6.
77. Basset F, Collet A, Chrétien J et al. Etude ultra-microscopique des cellules de la réaction de Kveim. In: Turiaf J, Chabot J, eds. Proceedings of the Fourth International Conference on Sarcoidosis 1966. Paris: Masson, 1967:89.
78. Douglas AC. Electron microscopy of Kveim and sarcoid lesions. In: Turiaf J, Chabot J, eds. Proceedings of the Fourth International Conference on Sarcoidosis 1966. Paris: Masson, 1967: 117.
79. Douglas SD, Siltzbach LE. Electron microscopy of Kveim biopsies in sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Tokyo: University Press, 1974: 54.
80. Hirsch JG, Fodorko ME, Dwyer CM. The ultrastructure of epithelioid and giant cells in positive Kveim test sites and sarcoid granulomata. In: Turiaf J, Chabot J, eds. Proceedings of the Fourth International Conference on Sarcoidosis 1966. Paris: Masson, 1967: 59.
81. Kalifat SR, Bouteille M, Delame J. Etude ultrastructurale des alterations cellulaires et extracellulaires dans le granulome sarcoidosique. In: Turiaf J, Chabot J, eds. Proceedings of the Fourth International Conference on Sarcoidosis 1966. Paris: Masson, 1967: 71.
82. Wanstrup J. On the ultrastructure of granuloma formation in sarcoidosis. In: Turiaf J, Chabot J, eds. Proceedings of the Fourth International Conference on Sarcoidosis 1966. Paris:Masson, 1967: 110.
83. James DG, Jopling WH. Sarcoidosis and leprosy. Trop Med Hyg 1961; 64: 42.
84. Kooij R. Sarcoidosis or leprosy? Br J Dermatol 1964; 76: 203.
85. Jordan JW, Darke CS. Chronic beryllium poisoning. Thorax 1958; 13: 69.
86. Slavin P. Diffuse pulmonary granulomatosis in young women following exposure to beryllium compounds in the manufacture of radio tubes. Am Rev Tuberc 1949; 60: 755.
87. Lurie HL. Five unusual cases of sporotrichosis from South Africa showing lesions in muscles, bones and viscera. Br J Surg 1963; 50: 585.
88. Anderson R, James DG, Peters PM, Thomson AD. Local sarcoid tissue reactions. Lancet 1962; i: 1211.
89. Hunninghake GW, Garrett KC, Richerson HB et al. Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis 1984; 130:476.
90. Crystal RG, Bitterman PB, Rennard SI et al. Interstitial lung diseases of unknown cause. N Engl J Med 1984; 310: 235.
91. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747.
92. Semenzato G. Immunology of interstitial lung disease: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection. Eur Respir J 1991; 4: 94.
93. Daniele RP, Dauber JH, Rossman MD. Immunologic abnormalities in sarcoidosis. Ann Intern Med 1980; 92: 406.
94. Gupta RC, Kueppers F, Deremee RA et al. Pulmonary and extra-pulmonary sarcoidosis in relation to circulating immune complexes:a quantitation of immune complexes by two radioimmunoassays. Am Rev Respir Dis 1977; 116: 261.
95. Saint-Remy J-MR, Mitchell DN, Cole PJ. Variation in immunoglobulin levels and circulating immune complexes in sarcoidosis. Am Rev Respir Dis 1983; 127: 23.
96. Lambre CR, Maho SL, Dibella G et al. Bronchoalveolar lavage fluid and serum complement activity in pulmonary sarcoidosis. Am Rev Respir Dis 1986; 134: 238.
97. Schoenfeld N, Schmolke B, Schmitt M et al. Specification and quantitation of circulating immune complexes in the serum of patients with active pulmonary sarcoidosis. Thorax 1994; 49: 688.
98. Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987; 135: 250.
99. Campbell DA, Poulter LW, Dubois RM et al. Immunocompetent cells in bronchoalveolar lavage reflect the cell population in transbronchial biopsies in pulmonary sarcoidosis. Am Rev Respir Dis 1985; 132: 1300.
100. Semenzato G, Chilosi M, Ossi E et al. Bronchoalveolar lavage and lung histology. Am Rev Respir Dis 1985; 132: 400.
101. Paradis IL, Dauber JH, Rabin BS. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133: 855.
102. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429.
103. Ceuppens JL, Lacquet LM, Marien G et al. Alveolar T cell subsets in pulmonary sarcoidosis. Am Rev Respir Dis 1984; 129: 563.
104. Rossi GA, Sacco O, Cosulich E et al. Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell sub-set imbalance at sites of disease activity. Thorax 1984; 39: 143.
105. Costabel U, Bross KJ, Ruhle KH et al. Ia-like antigens on T cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis. Am Rev Respir Dis 1985; 131: 337.
106. Hunninghake GW, Bedell GN, Zavala DC et al. Role of interleukin-2 release by lung T cells in active pulmonary sarcoidosis. Am Rev Respir Dis 1983; 128: 634.
107. Bauer W, Gorny MK, Baumann HR, Morell A. T lymphocyte sub-sets and immunoglobulin concentrations in bronchoalveolar lavage of patients with sarcoidosis and high and low intensity alveolitis. Am Rev Respir Dis 1985; 132: 1060.
108. Rankin JA, Naegel GP, Schrader CE et al. Air space immunoglobulin production and levels in bronchoalveolar lavage fluid of normal subjects and patients with sarcoidosis. Am Rev Respir Dis 1983; 127: 442.
109. Rossi GA, Sacco O, Cosulich E et al. Helper T lymphocytes in sarcoidosis. Am Rev Respir Dis 1986; 133: 1086.
110. Hunninghake GW, Line BR, Szapiel SV, Crystal RG. Activation of inflammatory cells increases the localisation of gallium-67 at sites of disease. Clin Res 1981; 29: 171A.
111. Hunninghake GW. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1984; 129: 569.
112. Hudspith BN, Flint KC, Geraint-James D et al. Lack of immune deficiency in sarcoidosis:compartmentalisation of the immune response. Thorax 1987; 42: 250.
113. Robinson BWS, Mclemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985; 75: 1488.
114. Limper AH, Colby TV, Sanders MS et al. Immunohistochemical localization of transforming growth factor b-1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149:197.
115. Hunninghake GW, Fulmer JD, Young RC et al. Localisation of the immune response in sarcoidosis. Am Rev Respir Dis 1979; 120: 49.
116. Chailleux E, Bignon JD, Peyrat MA et al. Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes and interleukin-2 production in sarcoidosis. Thorax 1985; 40: 768.
117. Anon. The immune response in sarcoidosis. Lancet 1987; ii: 195.
118. Chusid EL, Shah R, Siltzbach LE. Tuberculin tests during the course of sarcoidosis in 350 patients. Am Rev Respir Dis 1971; 104: 13.
119. Friou GJ. Delayed cutaneous hypersensitivity in sarcoidosis. J Clin Invest 1952; 31: 630.
120. Citron KM. Skin tests in sarcoidosis. Tubercle 1957; 38: 33.
121. Friou GJ. Astudy of the cutaneous reaction to didiomycin, trichophytin and mumps skin test antigens in patients with sarcoidosis. Yale J Biol Med 1952; 24: 233.
122. Sones M, Israel HL. Altered immunologic reactions in sarcoidosis. Ann Intern Med 1954; 40: 260.
123. James DG. Diagnosis and treatment of sarcoidosis. Br Med J 1956; 2: 900.
124. Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis. Analysis of 145 patients with a review of 9 series selected from the literature. Am J Med 1963; 35: 67.
125. Spann RW, Rosenow EC, Deremee RA, Miller WE. Unilateral hilar or paratracheal adenopathy in sarcoidosis: a study of 38 cases. Thorax 1971; 26: 296.
126. Williams MJ. Sarcoidosis presenting with unilateral hilar lymph node enlargement. Scott Med J 1961; 6: 18.
127. James DG. Erythema nodosum. Br Med J 1961; 1: 853.
128. Lofgren S. The concept of erythema nodosum revised. Scand J Respir Dis 1967; 48:348.
129. Sones M, Israel HL. Course and prognosis of sarcoidosis. Am J Med 1960; 29: 84.
130. Anderson J, Boughton CR. The concept of mediastinal pain. Br Med J 1957; 1: 1490.
131. Israel HL, Sones M, Roy RL, Stein GN. The occurrence of intrathoracic calcification in sarcoidosis. Am Rev Respir Dis 1961; 84: 1.
132. Israel HL, Lenchner G, Steiner RM. Late development of mediastinal calcification in sarcoidosis. Am Rev Respir Dis 1981; 124: 302.
133. Lofgren S, Lindgren AG. Cavern formation in pulmonary sarcoidosis. Acta Chir Scand 1959; Suppl 245: 113.
134. Tazi A, Desfemmes-Baleyte T, Soler P et al. Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph. Thorax 1994; 49: 793.
135. Wollschlager C, Khan F. Aspergillomas complicating sarcoidosis. Aprospective study in 100 patients. Chest 1984; 86: 585.
136. Farber HW, Fairman RP, Glauser FL. Talc granulomatosis: laboratory findings similar to sarcoidosis. Am Rev Respir Dis 1982; 125:258.
137. Middleton WG, Douglas AC. Prolonged corticosteroid therapy in pulmonary sarcoidosis. In: Jones Williams W, Davies BH, eds. Proceedings of the Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff: Alpha Omega, 1980: 632.
138. Hsu JT, Cottrell TS. Pulmonary sarcoidosis:unilateral hilar adenopathy presenting as an endobronchial tumour. Radiology 1971; 98:385.
139. Citron KM, Scadding JG. Stenosing noncaseating tuberculosis (sarcoidosis) of the bronchi. Thorax 1957; 12: 10.
140. di Benedetto RJ, Ribaudo C. Bronchopulmonary sarcoidosis. Am Rev Respir Dis 1966; 94: 952.
141. Miller A, Brown LK, Teirstein AS. Stenosis of main bronchi mimicking fixed upper airway obstruction in sarcoidosis. Chest 1980; 88:244.
142. Bechtel JJ, Starr T, Dantzker DR, Bower JS. Airway hyper-reactivity in patients with sarcoidosis. Am Rev Respir Dis 1981; 124: 759.
143. Olaffson M, Simonsson BG, Hansson S-B. Bronchial reactivity in patients with recent pulmonary sarcoidosis. Thorax 1985; 40: 51.
144. Kovnat PJ, Donohue RF. Sarcoidosis involving the pleura. Ann Intern Med 1965; 62: 120.
145. Wilen SB, Rabinowitz JG, Ulreich S, Lyons HA. Pleural involvement in sarcoidosis. Am J Med 1974; 57: 200.
146. Nicholls AJ, Friend JAR, Legge JS. Sarcoid pleural effusion: three cases and review of the literature. Thorax 1980; 35: 277.
147. Chusid EL, Shah R, Siltzbach LE. Sarcoidosis of the pleura. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Tokyo: University Press, 1974: 373.
148. Vital Durand D, Dellinger A, Guerin C et al. Pleural sarcoidosis: one case presenting with an eosinophilic effusion. Thorax 1984; 39: 468.
149. Gardiner IT, Uff JS. Acute pleurisy in sarcoidosis. Thorax 1978; 33: 124.
150. Morgans WE, Al-Jilahawi AN, Mbatha PB. Superior vena cava obstruction caused by sarcoidosis. Thorax 1980; 35: 397.
151. Hoffstein V, Ranganathan N, Mullen JBM. Sarcoidosis simulating pulmonary venoocclusive disease. Am Rev Respir Dis 1986; 134: 809.
152. Ainslie D, James DG. Ocular sarcoidosis. Br Med J 1956; 1: 954.
153. Cowan CL. Ocular sarcoidosis. J Natl Med Ass 1959; 51: 371.
154. James DG. Ocular sarcoidosis. Am J Med 1959; 26: 331.
155. Nielsen RH. Ocular sarcoidosis. AMAArch Ophthalmol 1959; 61: 455.
156. Nolan JP, Klatskin G. The fever of sarcoidosis. Ann Intern Med 1964; 61: 455.
157. MacFarlane JT. Recurrent erythema nodosum and pulmonary sarcoidosis. Postgrad Med J 1981; 57: 525.
158. Neville E, Mills RGS, Jash DK et al. Sarcoidosis of the upper respiratory tract and its association with lupus pernio. Thorax 1976; 31: 660.
159. Neville E, Mills RGS, James DG. Sarcoidosis of the upper respiratory tract and its relation to lupus pernio. Ann N Y Acad Sci 1976; 278:416.
160. Bower JS, Belen JE, Weg JG, Dantzker DR. Manifestations and treatment of laryngeal sarcoidosis. Am Rev Respir Dis 1980; 122: 325.
161. Tsou E, Romano MC, Kerwin DM et al. Sarcoidosis of anterior mediastinal nodes, pancreas and uterine cervix: three unusual sites in the same patient. Am Rev Respir Dis 1980; 122: 333.
162. McCormick PA, Malone D, Fitzgerald MX, Fitzgerald O. Pancreatitis in sarcoidosis. Br Med J 1985; 290: 1472.
163. Wheeler JE, Rosenthal NS. Bloody ascites in sarcoidosis. Chest 1985; 88: 917.
164. Fletcher J, Hinton JM. Tuberculin sensitivity in Crohn's disease. Lancet 1967; ii: 753.
165. Phear DN. The relation between regional ileitis and sarcoidosis. Lancet 1958; ii: 1250.
166. Anon. Kveim-Siltzbach test vindicated. Lancet 1972; i: 188.
167. Middleton WG, Douglas AC. Further experience with Edinburgh prepared Kveim-Siltzbach suspensions. In: Jones Williams W, Davies BH, eds. Proceedings of the Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff: Alpha Omega, 1980: 655.
168. Siltzbach LE. Kveim test in sarcoidosis. JAMA 1961; 178: 476.
169. Greenberg G, Anderson R, Sharpstow P, James DG. Enlargement of parotid gland due to sarcoidosis. Br Med J 1964; 2: 861.
170. Roberts JC, Rang MC. Sarcoidosis of liver and spleen. Lancet 1958; ii: 296.
171. Hirschman RJ, Johns CJ. Hemoglobin studies in sarcoidosis. Ann Intern Med 1965; 62: 129.
172. Aszkanazy CL. Sarcoidosis of the central nervous system. J Neuropathol 1952; 11: 392.
173. Campbell IW, Short AIK, Douglas AC. Hypothalamic manifestations of sarcoidosis - with particular reference to hypothalamic hypothyroidism. In: Jones Williams W, Davies BH, eds. Proceedings of the Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff: Alpha Omega, 1980: 579.
174. Colover J. Sarcoidosis with involvement of the central nervous system. Brain 1948; 71:451.
175. Cummins SD, Clark DH, Gandy TH. Boeck's sarcoid of the thyroid gland. Arch Pathol 1951; 51: 68.
176. Daum JJ, Canter HG, Katz S. Central nervous system sarcoidosis with alveolar hypoventilation. Am J Med 1965; 38: 893.
177. Douglas AC, Maloney AFJ. Sarcoidosis of the central nervous system. J Neurol Neurosurg Psychiatry 1973; 36: 1024.
178. Fazlullah S. Sarcoidosis with involvement of the nervous system. Dis Chest 1962; 41: 685.
179. Goodson WH. Neurological manifestations of sarcoidosis. South Med J 1960; 53: 1111.
180. Hook O. Sarcoidosis with involvement of the nervous system: report of nine cases. AMAArch Neurol Psychiatry 1954; 71: 554.
181. Jefferson M. Sarcoidosis of the nervous system. Brain 1957; 80: 540.
182. Jefferson M. The nervous system in sarcoidosis. Postgrad Med J 1958; 34: 259.
183. Jonasson JV. Sarcoidosis of the nervous system: report of four cases with interesting signs. Acta Psychiatr Scand 1960; 35: 182.
184. Matthews WB. Sarcoidosis of the nervous system. Br Med J 1959; 1: 267.
185. Nora JR, Levitsky JM, Zimmerman HJ. Sarcoidosis with panhypopituitarism and diabetes insipidus. Ann Intern Med 1959; 51:1400.
186. Schonell ME, Gillespie WJ, Maloney AEJ. Cerebral sarcoidosis. Br J Dis Chest 1968; 62:195.
187. Thompson JR. Sarcoidosis of the central nervous system: report of a case simulating intracranial neoplasm. Am J Med 1961; 31:977.
188. Walker AG. Sarcoidosis of the brain and spinal cord. Postgrad Med J 1961; 37: 431.
189. El-Kassimi FA, Ashour M, Vijayaraghavan R. Sarcoidosis presenting as recurrent laryngeal nerve palsy. Thorax 1990; 45: 565.
190. Jaffe R, Bogomolski-Yahalom V, Kramer MR. Vocal cord paralysis as the presenting symptom of sarcoidosis. Respir Med 1994; 88:633.
191. Pentland B, Mitchell JD, Cull RE, Ford MJ. Central nervous system sarcoidosis. Q J Med 1985; 56: 457.
192. Anon. Sarcoidosis of the nervous system. Lancet 1985; ii: 1048.
193. Winnacker JL, Becker KL, Katz S. Endocrine aspects of sarcoidosis. N Engl J Med 1969; 278: 483.
194. Delaney P. Neurologic manifestations in sarcoidosis. Review of the literature with a report of 23 cases. Ann Intern Med 1977; 87:336.
195. Vesely DL, Maldonodo A, Levey GS. Partial hypopituitarism and possible hypothalamic involvement in sarcoidosis. Report of a case and review of the literature. Am J Med 1977; 62: 425.
196. James DG, Thomson AD. The course of sarcoidosis and its modification by treatment. Lancet 1959; i: 1057.
197. Neville E, Carstairs LS, James DG. Sarcoidosis of bone. Q J Med 1977; 46: 215.
198. Crompton MR, Macdermott V. Sarcoidosis associated with progressive muscular wasting and weakness. Brain 1961; 84: 62.
199. Dyken PR. Sarcoidosis of the skeletal muscle: a case report and review of the literature. Neurology 1962; 12: 643.
200. Harvey JC. Amyopathy of Boeck's sarcoid. Am J Med 1959; 26: 356.
201. Powell LW. Sarcoidosis of the skeletal muscle. Report of 6 cases and review of the literature. Am J Clin Pathol 1953; 23: 881.
202. Rothfield B, Folk EE. Sarcoid myopathy. JAMA 1962; 179: 903.
203. Snorrason E. Myositis fibrosa progressiva. Lymphogranulomatosis benigna Boeck. (Fibrous progressive myositis in Boeck's benign lymphogranulomatosis). Nord Med 1947; 36: 2424.
204. Wallace SL, Lattes R, Malia JP, Ragan C. Muscle involvement in Boeck's sarcoid. Ann Intern Med 1958; 48: 497.
205. Douglas AC, MacLeod JG, Mathews JD. Symptomatic sarcoidosis of skeletal muscle. J Neurol Neurosurg Psychiatry 1973; 36: 1034.
206. Baydur A, Pandya K, Sharma OP, Kanel GC, Carlson M. Control of ventilation, respiratory muscle strength and granulomatous involvement of skeletal muscle in patients with sarcoidosis. Chest 1993; 103: 396.
207. Ost D, Yeldandi A, Cugell D. Acute sarcoidmyositis with respiratory muscle involvement. Chest 1995; 107: 879.
208. Ando DG, Lynch JP, Fantone JC. Sarcoid myopathy with elevated creatine phosphokinase. Am Rev Respir Dis 1985; 131: 298.
209. Kaplan H. Sarcoid arthritis. Arch Intern Med 1963; 112: 924.
210. Bell NH, Gill JR, Bartter FC. Calcium metabolism in sarcoidosis. Am Rev Respir Dis 1961; 84 (Suppl): 27.
211. Coburn JW, Hobbs C, Johnston GS et al. Granulomatous sarcoid nephritis. Am J Med 1967; 42: 273.
212. Lofgren S, Norbert R. Metabolic aspects of sarcoidosis. Acta Tuberc Scand 1959; Suppl 45: 40.
213. Lofgren S, Snellman B, Lindgren AG. Renal complications in sarcoidosis. Acta Med Scand 1957; 159: 296.
214. Ellman P, Parfitt AM. The resemblance between sarcoidosis with hypercalcaemia and hyperparathyroidism. Br Med J 1960; 2:108.
215. Goldstein RA, Israel HL, Becker KL, Moore CF. The infrequency of hypercalcaemia in sarcoidosis. Am J Med 1971; 51: 21.
216. Sandler LM, Winearls CG, Fraher J et al. Studies of the hypercalcaemia of sarcoidosis:effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25- dihydroxy vitamin D3. Q J Med 1984; 53: 165.
217. Taylor RL, Lynch HJ, Wysor WG. Seasonal influence of sunlight on the hypercalcaemia of sarcoidosis. Am J Med 1963; 34: 221.
218. Ogilvie RI, Kaye M, Moore S. Granulomatous sarcoid disease of the kidney. Ann Intern Med 1964; 61: 711.
219. Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of sarcoidosis. Thorax 1995; 50: 555.
220. Akmal M, Sharma OP. Renal sarcoidosis: a reminder. Chest 1990; 97: 1284.
221. Ryan DM, Lesser BA, Crumley LA et al. Epididymal sarcoidosis. J Urol 1993; 149:134.
222. Forbes G, Usher A. Fatal myocardial sarcoidosis. Br Med J 1962; 2: 771.
223. Anon. Sarcoid heart disease. Br Med J 1972; 4: 627.
224. Fleming HA. Sarcoid heart disease: a review and an appeal. Thorax 1980; 35: 641.
225. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993; 103: 253.
226. Stein E, Stimmel B, Siltzbach LE. Clinical course of cardiac sarcoidosis. Ann N Y Acad Sci 1976; 278: 470.
227. Mikhail JR, Mitchell DN, Ball KP. Abnormal electrocardiographic findings in sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Tokyo: University Press, 1974: 365.
228. Stein E, Jackler I, Stein W et al. Asymptomatic electrocardiographic alterations in 80 patients with sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Tokyo:University Press, 1974: 360.
229. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204.
230. Wait JL, Movahed A. Anginal chest pain in sarcoidosis. Thorax 1989; 44: 391.
231. Anon. Cardiac sarcoidosis. Thorax 1989; 44:371.
232. Demeter SL. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest 1988; 94: 202.
233. Scott J, Higenbotham T. Transplantation of the lungs and heart for patients with severe complications from sarcoidosis. Sarcoidosis 1990; 7: 9.
234. Paz HL, McCormick DJ, Kutalek SP, Patchefsky A. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest 1994; 106: 1603.
235. Ratner SJ, Fenoglio JJ, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest 1986; 90: 528.
236. Boushy SF, Kurtzman RS, Martin ND, Lewis BM. The course of pulmonary function in sarcoidosis. Ann Intern Med 1965; 62: 939.
237. Marshall R, Smellie HC, Baylis JH et al. Pulmonary function in sarcoidosis. Thorax 1958; 13: 48.
238. Marshall R, Karlish AJ. Lung function in sarcoidosis. Thorax 1971; 26: 402.
239. Sharma OP, Colp C, Williams MH. Course of pulmonary sarcoidosis with and without corticosteroid therapy as determined by pulmonary function studies. Am J Med 1966; 41: 541.
240. Svanborg N. Studies on cardiopulmonary function in sarcoidosis. Acta Med Scand 1961; Suppl 366.
241. Young RC, Carr C, Shelton TG et al. Sarcoidosis:relationship between changes in lung structure and function. Am Rev Respir Dis 1967; 95: 224.
242. Carrington CB, Gaensler EA, Mikus JP et al. Structure and function in sarcoidosis. Ann N Y Acad Sci 1976; 278: 265.
243. Bates DV, Macklem PT, Christie RV. Pulmonary sarcoidosis. In: Respiratory Function in Disease, 2nd edn.. London: WB Saunders, 1971: 287.
244. Sharma OP, Johnson R. Airway obstruction in sarcoidosis. Astudy of 123 non-smoking black American patients with sarcoidosis. Chest 1988; 94: 343.
245. Harrison BDW, Shaylor JM, Stokes TC, Wilkes AR. Airflow limitation in sarcoidosis:a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 1991; 85: 59.
246. Armstrong JR, Radke JR, Kvale PA, Eichenhorn MS, Popvich J. Endoscopic findings in sarcoidosis. Characteristics and correlations with radiographic staging and bronchial mucosal biopsy yield. Ann Otol 1981; 90:339.
247. Lewis MI, Horak DA. Airflow obstruction in sarcoidosis. Chest 1987; 92: 582.
248. Sietsema KE, Kraft M, Ginzton L, Sharma OP. Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 1992; 102: 838.
249. Douglas AC. The Kveim test and its practical significance. Scand J Respir Dis 1972; Suppl 80: 61.
250. Douglas AC, Wallace A, Clark J et al. The Edinburgh spleen: source of a validated Kveim Siltzbach test material. Ann N Y Acad Sci 1976; 278: 670.
251. Middleton WG, Douglas AC. Further experience with Edinburgh prepared Kveim-Siltzbach test suspensions. In: Jones Williams W, Davies BH, eds. Proceedings of the Eighth International Conference on Sarcoidosis and other Granulomatous Diseases. Cardiff: Alpha Omega, 1980: 655.
252. Munro CS, Mitchell DN. The Kveim response: still useful, still a puzzle. Thorax 1987; 42: 321.
253. Douglas AC. Experience with the Kveim test: conventional and freeze dried test substance. Acta Med Scand 1964; Suppl 425:189.
254. Siltzbach LE. Qualities and behaviour of satisfactory Kveim suspensions. Ann N Y Acad Sci 1976; 278: 665.
255. Anon. The Kveim controversy. Lancet 1971; ii: 750.
256. Siltzbach LE. Surveillance of Kveim test results. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Tokyo: University Press, 1974:79.
257. Nelson CT. The Kveim reaction in sarcoidosis. J Chron Dis 1957; 6: 158.
258. Kennedy WPU. An evaluation of freezedried Kveim reagent. Br J Dis Chest 1967; 61:40.
259. Rife E, Izumi T, Kallner A et al. On the active principle in the Kveim suspension. Scand J Respir Dis 1973; 54: 111.
260. Chase MW, Siltzbach LE. Further studies on the fractionation of materials used in the intracutaneous diagnostic test for sarcoidosis. Excerpta Med 1961; 42: 58.
261. Rogers FJ, Haserich JR. Sarcoidosis and the Kveim reaction. J Invest Dermatol 1954; 23:389.
262. Holter JF, Park KH, Sjoerdsma KW, Kataria YP. Non-viable autologous bronchoalveolar lavage cell preparations induce intradermal cell granulomas in sarcoidosis patients. Am Rev Respir Dis 1992; 145: 864.
263. Douglas AC. Kveim and Siltzbach. Mt Sinai J Med 1977; 44: 706.
264. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis. Am Rev Respir Dis 1980; 122: 721.
265. Polletti V, Patelli M, Spiga L et al. Transbronchial lung biopsy in pulmonary sarcoidosis. Chest 1986; 89: 361.
266. Lieberman J. Elevation of serum angiotensin-converting enzyme (ACE) levels in sarcoidosis. Am J Med 1975; 59: 365.
267. Lieberman J, Nosal A, Schleissner LA, Sastre-Foken A. Serum angiotensin converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis 1979; 120: 329.
268. Silverstein E, Pertschuk LP, Friedland J. Immuno-fluorescent localisation of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci USA 1979; 76: 6646.
269. Okabe T, Suzuki A, Ishikawa H et al. Cells originating from sarcoid granulomas in vitro. Am Rev Respir Dis 1981; 124: 608.
270. Mordelet-Dambrine MS, Stanislaus-Leguern GM, Huchon GJ et al. Elevation of the bronchoalveolar concentration of angiotensin-1 converting enzyme in sarcoidosis. Am Rev Respir Dis 1982; 126: 472.
271. Turton CWG, Grundy E, Firth G et al. Value of measuring serum angiotensin-1 converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax 1979; 34:57.
272. Deremee RA, Rohrbach MS. Normal serum angiotensin converting enzyme activity in patients with newly diagnosed sarcoidosis. Chest 1984; 85: 45.
273. Lawrence EC, Teague RB, Gottlieb MS et al. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis. Am J Med 1983; 74: 747.
274. Turner-Warwick M, Mcallister W, Lawrence R et al. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management. Thorax 1986; 41: 903.
275. Ueda E, Kawabe T, Tachibana T, Kokubu T. Serum angiotensin-converting enzyme activity as an indicator of prognosis in sarcoidosis. Am Rev Respir Dis 1980; 121: 667.
276. Baughman RP, Ploysongsang Y, Roberts RD, Srivastava L. Effect of sarcoid and steroids on angiotensin- converting enzyme. Am Rev Respir Dis 1983; 128: 631.
277. Gelrud LG, Arseneau JC, Milder MS et al. The kinetics of 67-gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med 1974; 83: 489.
278. Nosal A, Schleissner LA, Mishkin FS, Lieberman J. Angiotensin-1 converting enzyme and gallium scan in non-invasive evaluation of sarcoidosis. Ann Intern Med 1979; 90: 328.
279. Line BR, Hunninghake GW, Keogh BA et al. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical, studies pulmonary function studies and bronchoalveolar lavage. Am Rev Respir Dis 1981; 123: 440.
280. Cohen RD, Bunting PS, Meindok HO et al. Does serum angiotensin converting enzyme reflect intensity of alveolitis in sarcoidosis? Thorax 1985; 40: 497.
281. Israel HL, Albertine KH, Park CH, Patrick H. Whole-body gallium-67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991; 144: 1182.
282. Winterbauer RH, Wu R, Springmeyer SC. Fractional analysis of the 120-ml bronchoalveolar lavage. Determination of the best specimen for diagnosis of sarcoidosis. Chest 1993; 104: 344.
283. Winterbauer RH, Lammert J, Selland H et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993; 104:352.
284. Lynch DA, Webb WR, Gamsu G, Stalbarg M, Golden J. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 1989; 13: 405.
285. Brauer MW, Grenier P, Mompoint D, Lenoir S, De Cremoux H. Pulmonary sarcoidosis:evaluation with high resolution CT. Radiology 1989; 172: 467.
286. Muller NL, Miller RA. Computed tomography of chronic infiltrative lung disease. Am Rev Respir Dis 1990; 142: 1206.
287. Keogh BA, Hunninghake GW, Line BR, Crystal RG. The alveolitis of pulmonary sarcoidosis. Am Rev Respir Dis 1983; 128: 256.
288. Deremee RA. The present status of treatment of pulmonary sarcoidosis: a house divided. Chest 1977; 71: 388.
289. Young RL, Harkleroad LE, Lordon RE, Weg JG. Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med 1970; 73: 207.
290. Harklebroad LE, Young RL, Savage PJ et al. Pulmonary sarcoidosis. Long term follow up of the side effects of steroid therapy. Chest 1982; 82: 84.
291. Israel HL, Fouts DW, Beggs RA. Acontrolled trial of prednisolone treatment of sarcoidosis. Am Rev Respir Dis 1973; 107: 609.
292. Mikami R, Hiraga Y, Iwai K et al. Adoubleblind controlled trial on the effect of corticosteroid therapy in sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis. Tokyo:University Press, 1974: 538.
293. Selroos O, Sellergren TL. Corticosteroid therapy of pulmonary sarcoidosis: a prospective evaluation of alternate day and daily dosage of Stage II disease. Scand J Respir Dis 1979; 60: 215.
294. Eule H, Roth I, Weide W. Clinical and functional results of a controlled clinical trial of the value of prednisolone therapy in sarcoidosis, Stage I and II. In: Jones Williams W, Davies BH, eds. Proceedings of the Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff: Alpha Omega, 1980: 624.
295. Yamamoto M, Saito N, Tachibana T et al. Effects of an 18-month corticosteroid therapy on Stage I and II sarcoidosis patients (a controlled trial). In: Proceedings of the Ninth International Conference on Sarcoidosis. Oxford: Pergamon Press, 1983: 470.
296. Hunninghake GW, Gilbert S, Pueringer R et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994; 149: 893.
297. Johns CJ, Mcgregor MI, Zachary JB, Ball WC. Extended experience in the long term corticosteroid treatment of sarcoidosis. Ann N Y Acad Sci 1976; 278: 722.
298. Alberts C, Van Der Mark Thw Jansen HM et al. Inhaled budesonide in pulmonary sarcoidosis:a double blind placebo controlled study. Eur Respir J 1995; 8: 682.
299. Du Bois RM. Corticosteroids in sarcoidosis:friend or foe? Eur Respir J 1994; 7: 1203.
300. Kirsten D. Inhaled steroids for sarcoidosis? Eur Respir J 1995; 8: 679.
301. Rebuck AS, Stiller CR, Braude AC et al. Cyclosporin for pulmonary sarcoidosis. Lancet 1984; i: 1174.
302. Israel HL, Mccomb BL. Chlorambucil treatment of sarcoidosis. Sarcoidosis 1991; 8: 35.
303. Grizzants JN, Knapp AB, Sheeter AJ, Williams MH. Treatment of sarcoid meningitis with radiotherapy. Am J Med 1982; 73:605.